
Commentary|Podcasts|July 14, 2023
Pharmacy Focus: Psychedelic Pharmacy - Digital Therapeutics in Psychedelic Medicine
David Keene, vice president of Digital Therapeutics at atai Life Sciences, discussed the growth and future of digital therapeutics.
Advertisement
This month, we sat down with David Keene, vice president of Digital Therapeutics at atai Life Sciences, to discuss the growth and future of digital therapeutics.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
3
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
4
Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events
5


























